Multifunctional antibodies binding to EGFR and MET

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9328173
SERIAL NO

14573373

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are multifunctional antibodies, and/or antigen-binding fragments, that bind to, and inhibit the activity of, both human epidermal growth factor receptor (EGFR) and MET, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by EGFR and MET.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELI LILLY AND COMPANYLILLY CORPORATE CENTER INDIANAPOLIS INDIANA 46285

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aldaz, Hector San Marcos, US 3 7
Allan, Barrett Encinitas, US 17 668
Liu, Ling Carmel, US 149 924
Lu, Jirong Carmel, US 38 258
Tang, Ying San Diego, US 110 791
Tschang, Sheng-Hung Rainbow Carmel, US 8 501
Yachi, Pia Pauliina San Diego, US 5 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 3, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00